Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > SO MUCH FOR YOUR:
View:
Post by bolander on Apr 06, 2020 11:39pm

SO MUCH FOR YOUR:

WARRANTS...SO SAD !!
Comment by Sthlheadr on Apr 07, 2020 7:19am
well I seen that coming. You cant expect them to pay 2 bucks for warrants when they can buy at market for 16..... they were issued at a small premium I guess. Lol it is what it is. I'm sure the 2 dollar warrants would have expired soon
Comment by Sthlheadr on Apr 07, 2020 7:23am
the other half priced at 21 cents with a clause for forced excercise. Which is good
Comment by Sthlheadr on Apr 07, 2020 7:40am
because everyone knows that cheap paper can ruin a stock once it gets momentum
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities